As of 2025-01-25, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 12.89 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.64 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -78.0%.
The range of the Relative Valuation is 3.32 - 29.59 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.3x - 27.4x | 6.5x |
| Forward P/E multiples | 17.1x - 26.4x | 19.9x |
| Fair Price | 3.32 - 29.59 | 12.89 |
| Upside | -94.3% - -49.5% | -78.0% |
| Date | P/E |
| 2025-01-24 | 110.89 |
| 2025-01-23 | 110.98 |
| 2025-01-22 | 109.98 |
| 2025-01-21 | 110.34 |
| 2025-01-17 | 110.55 |
| 2025-01-16 | 108.73 |
| 2025-01-15 | 106.93 |
| 2025-01-14 | 102.41 |
| 2025-01-13 | 101.98 |
| 2025-01-10 | 104.08 |
| 2025-01-08 | 102.41 |
| 2025-01-07 | 102.83 |
| 2025-01-06 | 103.25 |
| 2025-01-03 | 104.95 |
| 2025-01-02 | 104.84 |
| 2024-12-31 | 104.53 |
| 2024-12-30 | 102.51 |
| 2024-12-27 | 102.89 |
| 2024-12-26 | 104.95 |
| 2024-12-24 | 102.41 |
| 2024-12-23 | 102.51 |
| 2024-12-20 | 100.88 |
| 2024-12-19 | 102.60 |
| 2024-12-18 | 101.89 |
| 2024-12-17 | 105.57 |
| 2024-12-16 | 106.57 |
| 2024-12-13 | 107.01 |
| 2024-12-12 | 106.95 |
| 2024-12-11 | 111.89 |
| 2024-12-10 | 111.87 |
| 2024-12-09 | 109.73 |
| 2024-12-06 | 107.73 |
| 2024-12-05 | 105.88 |
| 2024-12-04 | 107.52 |
| 2024-12-03 | 107.54 |
| 2024-12-02 | 109.43 |
| 2024-11-29 | 108.22 |
| 2024-11-27 | 112.30 |
| 2024-11-26 | 109.41 |
| 2024-11-25 | 110.89 |
| 2024-11-22 | 107.61 |
| 2024-11-21 | 105.63 |
| 2024-11-20 | 104.19 |
| 2024-11-19 | 105.31 |
| 2024-11-18 | 104.48 |
| 2024-11-15 | 106.99 |
| 2024-11-14 | 111.40 |
| 2024-11-13 | 113.14 |
| 2024-11-12 | 115.35 |
| 2024-11-11 | 116.75 |